Participant
Technical Services
Credential Services
Listed Company
Professional Adviser
Information Provider
Information Services
AMO
Notice
The securities of BARD1 Life Sciences Limited (previously Eurogold Limited) (the “Company”) were suspended from Official Quotation on 4 June 2013.
The securities of the Company will be reinstated to Official Quotation from the commencement of trading on 20 June 2016 following the Company’s compliance with listing rule 11.1.3 and Chapter 1 and 2 of the ASX Listing Rules.
Quoted securities: |
322,493,350 fully paid ordinary shares |
ASX code: |
BD1 |
Time: |
10:00 AM AEST (08:00 AM WST) |
Date: |
Monday, 20 June 2016 |
ASX Trade abbreviation: |
BARD1 LIFE |
ISIN: |
AU000000BD12 |
Home branch: |
Perth |
Industry classification: |
TBA |
Registered office: |
Unit B1 Tempo Building 431 Roberts Road Subiaco WA 6000 |
Company secretary: |
Pauline Collinson |
Share registry: |
Computershare Investor Services Pty Limited Level 11, 172 St Georges Terrace Perth WA 6000 |
Balance date: |
30 June |
CHESS: |
Participating. The Company will also operate an issuer sponsored sub-register. |
Place of incorporation: |
Western Australia. |
Dividend policy: |
See page 32 of the Company’s Replacement Prospectus dated 7 April 2016. |
Activities: |
Developing and commercialising a blood test for lung cancer detection. |
Restricted securities: |
229,503,236 shares classified as restricted securities for a period of 24 months from the date of reinstatement to official quotation of the securities. 217,003,236 Performance Shares classified as restricted securities for a period of 24 months from the date of reinstatement to official quotation of the securities. |
Securities not quoted: |
217,003,236 Performance Shares |
What do I need to do by when?
For further details, please refer to the Company’s prospectus.
Need more information?
Issued by
Frieda Orr, Adviser, Listings Compliance (Perth)
Contact information
Frieda Orr
+61 (08) 9224 0000
info@asx.com.au